Chief Scientific Officer @ (January 2019 - March 2022)
Executive Vice President, Drug Discovery @ (January 2012 - March 2022)
Senior Director @ (January 1995 - January 2011)
Post-doctoral fellow @ (January 1993 - January 1995)
Mark Bilodeau Education
Harvard University
Doctor of Philosophy (Ph.D.) (organic chemistry)
1988-1993
Boston College
Bachelor’s Degree (chemistry)
1984-1988
Mark Bilodeau Skills
Drug Discovery
Medicinal Chemistry
Leadership
Biotechnology
Neuroscience
Oncology
ADME
Intellectual Property
Mark Bilodeau Summary
Mark Bilodeau, based in Watertown, MA, US, is currently a Chief Scientific Officer at Kestrel Therapeutics. Mark Bilodeau brings experience from previous roles at Tarveda Therapeutics, Merck and Memorial Sloan-Kettering Cancer Center. Mark Bilodeau holds a 1988 - 1993 Doctor of Philosophy (Ph.D.) in organic chemistry @ Harvard University. With a robust skill set that includes Drug Discovery, Medicinal Chemistry, Leadership, Biotechnology, Neuroscience and more. Mark Bilodeau has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Bilodeau?
Find contact details for 700 million professionals.